The biology of ependymomas and emerging novel therapies
Ependymomas are rare central nervous system tumours that can arise in the brain's
supratentorial region or posterior fossa, or in the spinal cord. In 1924, Percival Bailey …
supratentorial region or posterior fossa, or in the spinal cord. In 1924, Percival Bailey …
Pediatric ependymoma: biological perspectives
JP Kilday, R Rahman, S Dyer, L Ridley, J Lowe… - Molecular Cancer …, 2009 - AACR
The sphingomyelin (SM) cycle is an emerging pathway of signal transduction that plays a
role in the control of cell growth, cell differentiation, and apoptosis. During earlier …
role in the control of cell growth, cell differentiation, and apoptosis. During earlier …
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
Background Identification of robust biomarkers of malignancy and methods to establish
disease progression is a major goal in paediatric neuro-oncology. We investigated whether …
disease progression is a major goal in paediatric neuro-oncology. We investigated whether …
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts
Background Histopathological grading of ependymoma has been controversial with respect
to its reproducibility and clinical significance. In a 3-phase study, we reviewed the pathology …
to its reproducibility and clinical significance. In a 3-phase study, we reviewed the pathology …
Molecular staging of intracranial ependymoma in children and adults
Purpose The biologic behavior of intracranial ependymoma is unpredictable on the basis of
current staging approaches. We aimed at the identification of recurrent genetic aberrations …
current staging approaches. We aimed at the identification of recurrent genetic aberrations …
A prognostic gene expression signature in infratentorial ependymoma
K Wani, TS Armstrong, E Vera-Bolanos… - Acta …, 2012 - Springer
Patients with ependymoma exhibit a wide range of clinical outcomes that are currently
unexplained by clinical or histological factors. Little is known regarding molecular …
unexplained by clinical or histological factors. Little is known regarding molecular …
Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival
AE Marinoff, C Ma, D Guo, M Snuderl, KD Wright… - Journal of neuro …, 2017 - Springer
Ependymoma is the third most common brain tumor in children, but there is a paucity of
large studies with more than 10 years of follow-up examining the long-term survival and …
large studies with more than 10 years of follow-up examining the long-term survival and …
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor …
R Salloum, TR Hummel, SS Kumar, K Dorris… - Journal of neuro …, 2016 - Springer
Telomerase activation is critical in many cancers including central nervous system (CNS)
tumors. Imetelstat is an oligonucleotide that binds to the template region of the RNA …
tumors. Imetelstat is an oligonucleotide that binds to the template region of the RNA …
Childhood brain tumors: epidemiology, current management and future directions
IF Pollack, RI Jakacki - Nature Reviews Neurology, 2011 - nature.com
Brain tumors are the most common solid tumors in children. With the increasingly
widespread availability of MRI, the incidence of childhood brain tumors seemed to rise in the …
widespread availability of MRI, the incidence of childhood brain tumors seemed to rise in the …
Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective …
Purpose: The high incidence of recurrence and unpredictable clinical outcome for pediatric
ependymoma reflect the imprecision of current therapeutic staging and need for novel risk …
ependymoma reflect the imprecision of current therapeutic staging and need for novel risk …